| |
| |
|
| Insider
Information: |
Skaletsky Mark B |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
30,091 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$558,888 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,091 |
|
|
| Total
Value |
$558,888 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2004-07-01 |
13,759 |
2003-07-14 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2010-11-17 |
11,332 |
|
0 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2007-03-08 |
0 |
2007-03-08 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2011-09-16 |
5,000 |
2011-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Director |
– • – |
2011-09-16 |
4/A |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
– • – |
2011-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-17 |
4 |
S |
$22.00 |
$649,000 |
D/D |
(29,500) |
11,332 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-17 |
4 |
OE |
$2.71 |
$213,145 |
D/D |
29,500 |
40,832 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-16 |
4 |
S |
$21.76 |
$65,295 |
D/D |
(3,000) |
11,332 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-11-16 |
4 |
OE |
$2.71 |
$8,130 |
D/D |
3,000 |
14,332 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2007-03-08 |
4 |
AS |
$56.42 |
$1,136,815 |
D/D |
(20,000) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2007-03-08 |
4 |
OE |
$8.98 |
$219,200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,332 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2004-07-01 |
4 |
A |
$6.07 |
$4,498 |
D/D |
741 |
13,759 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2004-04-01 |
4 |
A |
$6.72 |
$4,496 |
D/D |
669 |
13,018 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2004-01-02 |
4 |
A |
$5.05 |
$4,500 |
D/D |
891 |
12,349 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2003-10-01 |
4 |
A |
$4.45 |
$4,499 |
D/D |
1,011 |
11,458 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2003-07-14 |
4 |
A |
$4.27 |
$2,998 |
D/D |
702 |
10,447 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
